All
Biden Infrastructure Package Would Boost R&D and Corporate Taxes
April 2nd 2021The White House’s American Jobs Plan includes investment in new technologies for rapid scale up of vaccine production, in expanded emergency production capacity and enhanced US infrastructure for biopreparedness, and in greater production onshore of APIs.
Sanofi to Invest More than $700 million into New Canadian Vaccine Manufacturing Facility
March 31st 2021Set to be operational in 2026, the new facility will provide added antigen and filling capacity for Sanofi’s influenza vaccine, increasing its availability in Canada, the United States, and Europe.
J&J to Supply the African Union with 200 Million Doses of its COVID-19 Vaccine
March 29th 2021The company has entered into an agreement with the African Vaccine Acquisition Trust for the supply of 220 million doses of its single-shot COVID-19 vaccine for the African Union’s 55 member states beginning in the third quarter of 2021.
BioCentriq to Partner with Kytopen for Cell Therapy Manufacturing
March 25th 2021The companies will work together to determine the impact on autologous and allogeneic cell therapies by combining Kytopen’s proprietary Flowfect technology for non-viral cell engineering with other steps in the manufacturing process.